Shopping Cart
Remove All
Your shopping cart is currently empty
Orilanolimab (SYNT 001, ALXN 1830) is a humanised and deimmunised monoclonal antibody targeting FcRn, disrupting the interaction between FcRn and IgG, and may be used in immunology research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $455 | - | In Stock | |
| 5 mg | $1,180 | - | In Stock | |
| 10 mg | $1,890 | - | In Stock | |
| 25 mg | $2,820 | - | In Stock | |
| 50 mg | $3,780 | - | In Stock |
| Description | Orilanolimab (SYNT 001, ALXN 1830) is a humanised and deimmunised monoclonal antibody targeting FcRn, disrupting the interaction between FcRn and IgG, and may be used in immunology research. |
| In vitro | In primary CD11c+ APCs derived from B2MTG/TGFCGRTTG/TG Fcgrt-/- mice, Orilanolimab (10nM, 50nM, and 100nM,48 hours) suppressed IFN-γ secretion by OVA-specific CD8+ and CD4+ T cells [1]. |
| In vivo | In hFcRn-expressing mouse models, Orilanolimab (20 mg/kg, intravenous injection) significantly reduced the levels of human IgG and IgG ICs in plasma [1]. Orilanolimab (10, 30, 100 mg/kg, intravenous injection, once weekly) induced a dose-dependent and proposed reduction in total circulating IgG levels in cynomolgus monkeys [1]. |
| Synonyms | SYNT001, SYNT 001, ALXN1830, ALXN 1830 |
| Cas No. | 2066544-85-0 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.